Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.

[1]  H. Ji,et al.  Doxepin protects cultured neurons against oxidative stress-induced injury. , 2004, Acta pharmacologica Sinica.

[2]  S. Armstrong Protein kinase activation and myocardial ischemia/reperfusion injury. , 2004, Cardiovascular research.

[3]  Geng-tao Liu,et al.  Isorhapontigenin and resveratrol suppress oxLDL-induced proliferation and activation of ERK1/2 mitogen-activated protein kinases of bovine aortic smooth muscle cells. , 2004, Biochemical pharmacology.

[4]  M. Runge,et al.  Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-κB (NF-κB) transcription factor , 2004, Molecular and Cellular Biochemistry.

[5]  Yen-Ling Chen,et al.  Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  S. Pervaiz Resveratrol: from grapevines to mammalian biology , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  D. Kuppuswamy,et al.  RGD-containing Peptides Activate S6K1 through β3 Integrin in Adult Cardiac Muscle Cells* , 2003, Journal of Biological Chemistry.

[8]  Colin Sumners,et al.  Angiotensin II induction of AP-1 in neurons requires stimulation of PI3-K and JNK. , 2003, Biochemical and biophysical research communications.

[9]  P. Ping Identification of novel signaling complexes by functional proteomics. , 2003, Circulation research.

[10]  J. Molkentin,et al.  Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy? , 2003, Circulation.

[11]  Y. Ahn,et al.  A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response , 2003, Circulation.

[12]  A. Cinelli,et al.  Intracellular Na+ Regulates Dopamine and Angiotensin II Receptors Availability at the Plasma Membrane and Their Cellular Responses in Renal Epithelia* , 2003, Journal of Biological Chemistry.

[13]  S. Tominaga,et al.  Tumor Necrosis Factor-induced Nuclear Factor κB Activation Is Impaired in Focal Adhesion Kinase-deficient Fibroblasts* , 2003, Journal of Biological Chemistry.

[14]  Z. Estrov,et al.  Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. , 2003, Blood.

[15]  Y. Yamori,et al.  Antioxidant nutrients and hypoxia/ischemia brain injury in rodents. , 2003, Toxicology.

[16]  B. Kobilka,et al.  Myocyte Adrenoceptor Signaling Pathways , 2003, Science.

[17]  P. Golino,et al.  Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. , 2003, Journal of the American College of Cardiology.

[18]  J. Maller Fishing at the Cell Surface , 2003, Science.

[19]  Mark Ptashne,et al.  Imposing Specificity on Kinases , 2003, Science.

[20]  L. Gendron,et al.  Cyclic AMP-independent Involvement of Rap1/B-Raf in the Angiotensin II AT2 Receptor Signaling Pathway in NG108-15 Cells* , 2003, The Journal of Biological Chemistry.

[21]  Sujay K. Singh,et al.  Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis , 2003 .

[22]  A. Lin,et al.  Activation of nuclear factor- B is necessary for myotrophin-induced cardiac hypertrophy , 2002 .

[23]  Sanjeev Banerjee,et al.  Piceatannol Inhibits TNF-Induced NF-κB Activation and NF-κB-Mediated Gene Expression Through Suppression of IκBα Kinase and p65 Phosphorylation1 , 2002, The Journal of Immunology.

[24]  A. Vollmar,et al.  Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. , 2002, Molecular pharmacology.

[25]  C. Kahn,et al.  Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways , 2002, Cell.

[26]  P. Seshiah,et al.  Angiotensin II Stimulation of NAD(P)H Oxidase Activity: Upstream Mediators , 2002, Circulation research.

[27]  Sanjeev Banerjee,et al.  Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. , 2002, Cancer research.

[28]  S. Eguchi,et al.  Angiotensin II–Induced Cardiac Hypertrophy and Hypertension Are Attenuated by Epidermal Growth Factor Receptor Antisense , 2002, Circulation.

[29]  A. Takeshita,et al.  Probucol Attenuates Left Ventricular Dysfunction and Remodeling in Tachycardia-Induced Heart Failure: Roles of Oxidative Stress and Inflammation , 2002, Circulation.

[30]  D. Mann,et al.  Angiotensin II Induces Tumor Necrosis Factor Biosynthesis in the Adult Mammalian Heart Through a Protein Kinase C-Dependent Pathway , 2002, Circulation.

[31]  Youngsoo Kim,et al.  Oxyresveratrol and Hydroxystilbene Compounds , 2002, The Journal of Biological Chemistry.

[32]  M. Nelson,et al.  Molecular physiology: Protecting the heart , 2002, Nature.

[33]  M. Hori,et al.  The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. , 2002, Journal of the American College of Cardiology.

[34]  Geng-tao Liu,et al.  Effect of isorhapontigenin on respiratory burst of rat neutrophils. , 2002, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[35]  Su Ph Signalling pathways in cardiac myocyte hypertrophy. , 2001 .

[36]  K. Node,et al.  Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. , 2001, The Journal of clinical investigation.

[37]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[38]  Q. Wang,et al.  Antioxidative activity of natural isorhapontigenin. , 2001, Japanese journal of pharmacology.

[39]  P. Lucchesi,et al.  Down-regulation by Antisense Oligonucleotides Establishes a Role for the Proline-rich Tyrosine Kinase PYK2 in Angiotensin II-induced Signaling in Vascular Smooth Muscle* , 2001, The Journal of Biological Chemistry.

[40]  B. Gontero,et al.  Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. , 2000, Journal of molecular and cellular cardiology.

[41]  S. Manna,et al.  Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation1 , 2000, The Journal of Immunology.

[42]  N. Maulik,et al.  Myocardial protection with red wine extract. , 2000, Journal of cardiovascular pharmacology.

[43]  L. Graves,et al.  Protein Kinase C and Protein Kinase A Inhibit Calcium-dependent but not Stress-dependent c-Jun N-terminal Kinase Activation in Rat Liver Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[44]  D. T. Yue Quenching the Spark in the Heart , 1997, Science.